The drug has been approved for the treatment of adult patients with complicated urinary tract infections (cUTI), including pyelonephritis, as well as infections accompanied by Gram-negative bacteremia.
Wockhardt shares jump 9% after CDSCO approves breakthrough antibiotic Zaynich in India
Source: Cnbctv18
Read Full Story →
_in_CGWB.jpg)